
51 - 200 employees
Founded 2015
💊 Pharmaceuticals
🏥 Healthcare
💰 $16.6M Post-IPO Equity - Aytu BioPharma on 2025-06
Pharmaceuticals • Healthcare
Aytu BioPharma is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases to improve patients' quality of life. The company concentrates on psychiatric conditions, notably major depressive disorder (MDD) and attention deficit/hyperactivity disorder (ADHD), and lists products such as the EXXUA™ ADHD portfolio and pediatric offerings. Aytu emphasizes patient access and support programs, characterizing its approach as developing novel therapeutics while ensuring broad access. Key facts in the provided information include a founding year of 2000, headquarters in Denver, Colorado, and the ticker symbol AYTU.
🕒 June 26
Medical Science Liaison engaging healthcare professionals and researchers for Aytu BioPharma's therapeutic assets. Bridging scientific functions with the medical community for effective communication.
⛰️ Colorado – Remote
💵 $180k - $190k / year
💰 $16.6M Post-IPO Equity - Aytu BioPharma on 2025-06
⏰ Full Time
🟢 Junior
✨ Medical Science Liaison